Effect of Visceral Disease Site on Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Enzalutamide in the PREVAIL Trial
Titel:
Effect of Visceral Disease Site on Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Enzalutamide in the PREVAIL Trial
Auteur:
Alumkal, Joshi J. Chowdhury, Simon Loriot, Yohann Sternberg, Cora N. de Bono, Johann S. Tombal, Bertrand Carles, Joan Flaig, Thomas W. Dorff, Tanya B. Phung, De Forer, David Noonberg, Sarah B. Mansbach, Hank Beer, Tomasz M. Higano, Celestia S.